Israeli Nanodrug 'Attacks Cancer Twice' by Boosting Chemotherapy Effects and Immune System
'It increases the sensitivity of cancer cells resistant to chemotherapy, while also reinvigorating immune cells.'
Stay updated with breaking news from Dan Peer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'It increases the sensitivity of cancer cells resistant to chemotherapy, while also reinvigorating immune cells.'
Tel Aviv University researchers develop nanoparticles able to utilize RNA to overcome resistance to both chemotherapy and immunotherapy in cancer treatments and open a new path to a personalized and precisely targeted battle against cancer
Ag-biotech company PlantArcBio and TAU to collaborate on the development of RNAi-based products and environmentally friendly solutions.
New Phase nanotech company aims to transform end-stage cancer from a likely death sentence to a chronic illness.
The ERC (European Research Council) grant, annually awarded by the European Union, is considered one of the most prestigious and important research grants in the world of science.